Tilray | TRLY - Costo Del Venduto





Costo Del Venduto Cambiamento Data
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Cronos Group USD 26.48M 2.26M 2026-03
Divis Laboratories Ltd INR 12.39B 1.76B 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
IQVIA Holdings USD 3.08B 161M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Moderna USD 955M 503M 2026-03
Organigram Holdings CAD 56.93M 20.53M 2025-12
Organon & Co USD 766M 21M 2025-12
Revvity USD 323.46M 26.93M 2026-03
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.36B 195.9M 2026-03
Xeris Pharmaceuticals USD 13.66M 49K 2025-12
Zealand Pharma A/S 410K 5K 2025-06